Literature DB >> 22318329

Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies.

W S Yoon1, D S Yang, J A Lee, S Lee, Y J Park, C Y Kim.   

Abstract

PURPOSE: The goal of the present study was to demonstrate risk factors affecting the interfractional variation in whole pelvic irradiation. PATIENTS AND METHODS: Daily image acquisitions of 101 patients with locally advanced pelvic malignancy were undertaken using a kilo-voltage orthogonal on-board imager. The baseline deviation (the shift between the initial treatment and each fraction; Value(Base)) and day-to-day variation (the shift between the previous treatment and each fraction; Value(DD)) were measured. The standard deviations (SD) along the x- (right-left), y- (cranial-caudal), and z- (anterior-posterior) axes (SD[x], SD[y], and SD[z], respectively), the 3D vector of the SD (SD[3D]), and the mean of 3D shift (mean[3D]) were calculated in each patient. Various clinical factors, lumbar pelvic balance and rotation, and the shift of 5 consecutive fractions from the initial treatment (Value(5Fx)) were investigated as risk factors.
RESULTS: The prone set-up showed a larger mean(Base)[3D] than in the supine position (p =0 .063). A body mass index (BMI) ≥ 30 kg/m(2) resulted in the largest mean(DD)[3D] (p = 0.078) and SD(DD)[3D] (p = 0.058). All the SD(5Fx) along the x-, y-, and z-axes had moderate linear relationships with SD(Base) and SD(DD) (p < 0.001). The SD(5Fx)[3D] also had a moderate linear relationship with the mean(Base)[3D], mean(DD)[3D], SD(Base)[3D], and SD(DD)[3D] (p < 0.001). In multivariate analysis, the SD(5Fx) had the same significant relationship with SD(Base) and SD(DD) (p < 0.001). A BMI ≥ 30 kg/m(2) was associated with the largest SD(DD)[x] (p = 0.003).
CONCLUSION: Close surveillance through high-quality and frequent image guidance is recommended for patients with extensive variations of the initial five consecutive fractions or obesity.

Entities:  

Mesh:

Year:  2012        PMID: 22318329     DOI: 10.1007/s00066-011-0049-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  29 in total

1.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

2.  A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.

Authors:  Helen A McNair; Vibeke N Hansen; Christopher C Parker; Phil M Evans; Andrew Norman; Elizabeth Miles; Emma J Harris; Louise Del-Acroix; Elizabeth Smith; Richard Keane; Vincent S Khoo; Alan C Thompson; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

3.  Generic planning target margin for rectal cancer treatment setup variation.

Authors:  John M Robertson; Jonathon P Campbell; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-07       Impact factor: 7.038

Review 4.  kV cone-beam CT-based IGRT: a clinical review.

Authors:  Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

5.  Increasing treatment accuracy for cervical cancer patients using correlations between bladder-filling change and cervix-uterus displacements: proof of principle.

Authors:  Rozilawati Ahmad; Mischa S Hoogeman; Maria Bondar; V Dhawtal; Sandra Quint; Ilse De Pree; Jan Willem Mens; Ben J M Heijmen
Journal:  Radiother Oncol       Date:  2011-02-04       Impact factor: 6.280

6.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

7.  Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

Authors:  Michael Pinkawa; Marc D Piroth; Richard Holy; Victoria Djukic; Jens Klotz; Barbara Krenkel; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2011-07-25       Impact factor: 3.621

8.  Estimation of transverse plane pelvic rotation using a posterior-anterior radiograph.

Authors:  Brennen Lucas; Marc Asher; Terence McIff; Richard Lark; Douglas Burton
Journal:  Spine (Phila Pa 1976)       Date:  2005-01-01       Impact factor: 3.468

9.  Effect of the first day correction on systematic setup error reduction.

Authors:  Qiuwen Wu; David Lockman; John Wong; Di Yan
Journal:  Med Phys       Date:  2007-05       Impact factor: 4.071

10.  Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy.

Authors:  Reinhold Graf; Peter Wust; Volker Budach; Dirk Boehmer
Journal:  Radiat Oncol       Date:  2009-04-27       Impact factor: 3.481

View more
  9 in total

1.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

2.  Influence of position and radiation technique on organs at risk in radiotherapy of rectal cancer.

Authors:  Jun-Feng Wang; Hui Li; Hua Xiong; He Huang; Yan-Mei Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

3.  Set-up uncertainty during breast radiotherapy. Image-guided radiotherapy for patients with initial extensive variation.

Authors:  D S Yang; W S Yoon; S Y Chung; J A Lee; S Lee; Y J Park; C Y Kim; G S Son
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

Review 4.  Obesity and cancer: at the crossroads of cellular metabolism and proliferation.

Authors:  Robert W O'Rourke
Journal:  Surg Obes Relat Dis       Date:  2014-08-27       Impact factor: 4.734

5.  Small bowel protection in IMRT for rectal cancer : A dosimetric study on supine vs. prone position.

Authors:  Julia Koeck; Katharina Kromer; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Sabine Mai; Sylvia Büttner; Jens Fleckenstein; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2017-02-20       Impact factor: 3.621

6.  Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei.

Authors:  P Berkovic; L van de Voorde; G De Meerleer; L Delrue; B Speleers; S Van Belle; K Vandecasteele
Journal:  Strahlenther Onkol       Date:  2013-12-06       Impact factor: 3.621

7.  Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy.

Authors:  Avinash Badajena; Vijay Parshuram Raturi; Kirti Sirvastava; Hidehiro Hojo; Hajime Ohyoshi; Yanping Bei; Toshiya Rachi; Chen-Ta Wu; Taku Tochinai; Masayuki Okumura; Haiqin Zhang; Hirotaki Kouta; Pragya Verma; Geeta Singh; Abhishek Anand; Anjali Sachan
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-22

8.  A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients.

Authors:  Trude C Frøseth; Trond Strickert; Kjersti S Solli; Øyvind Salvesen; Gunilla Frykholm; Randi J Reidunsdatter
Journal:  Radiat Oncol       Date:  2015-10-27       Impact factor: 3.481

Review 9.  Proton therapy- the modality of choice for future radiation therapy management of Prostate Cancer?

Authors:  Sophie Mangan; Michelle Leech
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.